Epstein-Barr virus.
Junker
Anne K
AK
Division of Infectious and Immunological Diseases, Department of Pediatrics, University of British Columbia and Children's & Women's Health Centre of British Columbia, Vancouver, BC, Canada.
D000667:Ampicillin / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000914:Antibodies, Viral; D001402:B-Lymphocytes / Q000821:virology; D002051:Burkitt Lymphoma / Q000821:virology; D002648:Child; D004279:DNA, Viral / Q000032:analysis; D003937:Diagnosis, Differential; D020031:Epstein-Barr Virus Infections / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D004854:Herpesvirus 4, Human / Q000254:growth & development / Q000276:immunology; D006801:Humans; D008232:Lymphoproliferative Disorders; D009303:Nasopharyngeal Neoplasms / Q000821:virology; D016133:Polymerase Chain Reaction
D000900:Anti-Bacterial Agents; D000914:Antibodies, Viral; D004279:DNA, Viral; D000667:Ampicillin